{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:44:44Z","timestamp":1787507084942,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12664-023-01457-2","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T20:02:31Z","timestamp":1701374551000},"page":"536-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review"],"prefix":"10.1007","volume":"43","author":[{"given":"Walter","family":"Masson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-1083","authenticated-orcid":false,"given":"Leandro","family":"Barbagelata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddison","family":"Godinez-Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Genua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Patricio","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"1457_CR1","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"1457_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:20\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1457_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/cld.722","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357. https:\/\/doi.org\/10.1002\/cld.722.","journal-title":"Hepatology"},{"key":"1457_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","volume":"22","author":"V Manne","year":"2018","unstructured":"Manne V, Handa P, Kowdley KV. Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22:23\u201337. https:\/\/doi.org\/10.1016\/j.cld.2017.08.007.","journal-title":"Clin Liver Dis"},{"key":"1457_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158:1999\u20132014. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"key":"1457_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"key":"1457_CR7","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238. https:\/\/doi.org\/10.1016\/j.molmet.2021.101238.","journal-title":"Mol Metab."},{"key":"1457_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jacl.2022.10.004","volume":"17","author":"S Simantiris","year":"2023","unstructured":"Simantiris S, Antonopoulos AS, Papastamos C, et al. Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease. J Clin Lipidol. 2023;17:55\u201363. https:\/\/doi.org\/10.1016\/j.jacl.2022.10.004.","journal-title":"J Clin Lipidol"},{"key":"1457_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese M, Cabrera D, Kalergis AM, Feldstein AE. Innate Immunity and Inflammation in NAFLD\/NASH. Dig Dis Sci. 2016;61:1294\u2013303. https:\/\/doi.org\/10.1007\/s10620-016-4049-x.","journal-title":"Dig Dis Sci"},{"key":"1457_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","volume":"67","author":"PR Kamstrup","year":"2021","unstructured":"Kamstrup PR. Lipoprotein(a) and cardiovascular disease. Clin Chem. 2021;67:154\u201366. https:\/\/doi.org\/10.1093\/clinchem\/hvaa247.","journal-title":"Clin Chem"},{"key":"1457_CR11","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.3390\/jcm11206040","volume":"11","author":"HS Bhatia","year":"2022","unstructured":"Bhatia HS, Wilkinson MJ. Lipoprotein(a): Evidence for role as a causal risk factor in cardiovascular disease and emerging therapies. J Clin Med. 2022;11:6040. https:\/\/doi.org\/10.3390\/jcm11206040.","journal-title":"J Clin Med"},{"key":"1457_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00004836-200308000-00017","volume":"37","author":"M Koruk","year":"2003","unstructured":"Koruk M, Sava\u015f MC, Yilmaz O, et al. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol. 2003;37:177\u201382. https:\/\/doi.org\/10.1097\/00004836-200308000-00017.","journal-title":"J Clin Gastroenterol"},{"key":"1457_CR13","doi-asserted-by":"publisher","unstructured":"Priya MT, Sheriff DS. A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients. Libyan J Med. 2010;5. https:\/\/doi.org\/10.3402\/ljm.v5i0.5071.","DOI":"10.3402\/ljm.v5i0.5071"},{"key":"1457_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jgh.12077","volume":"28","author":"YG Choe","year":"2013","unstructured":"Choe YG, Jin W, Cho YK, et al. Apolipoprotein B\/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects. J Gastroenterol Hepatol. 2013;28:678\u201383. https:\/\/doi.org\/10.1111\/jgh.12077.","journal-title":"J Gastroenterol Hepatol"},{"key":"1457_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2016.07.003","volume":"461","author":"JS Nam","year":"2016","unstructured":"Nam JS, Jo S, Kang S, Ahn CW, Kim KR, Park JS. Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults. Clin Chim Acta. 2016;461:14\u20138. https:\/\/doi.org\/10.1016\/j.cca.2016.07.003.","journal-title":"Clin Chim Acta"},{"key":"1457_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-020-01310-x","volume":"19","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, He H, Zeng YP, et al. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study. Lipids Health Dis. 2020;19:134. https:\/\/doi.org\/10.1186\/s12944-020-01310-x.","journal-title":"Lipids Health Dis"},{"key":"1457_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.07.020","volume":"308","author":"I Jung","year":"2020","unstructured":"Jung I, Kwon H, Park SE, et al. Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease. Atherosclerosis. 2020;308:1\u20135. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.07.020.","journal-title":"Atherosclerosis"},{"key":"1457_CR18","doi-asserted-by":"publisher","first-page":"691556","DOI":"10.3389\/fendo.2021.691556","volume":"12","author":"T Wu","year":"2021","unstructured":"Wu T, Ye J, Shao C, et al. Varied relationship of lipid and lipoprotein profiles to liver fat content in phenotypes of metabolic associated fatty liver disease. Front Endocrinol (Lausanne). 2021;12:691556. https:\/\/doi.org\/10.3389\/fendo.2021.691556.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1457_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/nu13020552","volume":"13","author":"V Esteve-Luque","year":"2021","unstructured":"Esteve-Luque V, Padr\u00f3-Miquel A, Fanlo-Maresma M, et al. Implication between genetic variants from APOA5 and ZPR1 and NAFLD severity in patients with hypertriglyceridemia. Nutrients. 2021;13:552. https:\/\/doi.org\/10.3390\/nu13020552.","journal-title":"Nutrients."},{"key":"1457_CR20","doi-asserted-by":"publisher","first-page":"e0253298","DOI":"10.1371\/journal.pone.0253298","volume":"16","author":"S Sukahri","year":"2021","unstructured":"Sukahri S, Mohamed Shah FZ, Ismail AI,\u00a0et al. Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. PLoS One. 2021;16:e0253298. https:\/\/doi.org\/10.1371\/journal.pone.0253298.","journal-title":"PLoS One."},{"key":"1457_CR21","doi-asserted-by":"publisher","first-page":"e00504","DOI":"10.14309\/ctg.0000000000000504","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu T, Ye J, Shao C, et al. The ability of lipoprotein (a) level to predict early carotid atherosclerosis Is impaired in patients with advanced liver fibrosis relared to metabolic-associated fatty liver disease. Clin Transl Gastroenterol. 2022;13:e00504. https:\/\/doi.org\/10.14309\/ctg.0000000000000504.","journal-title":"Clin Transl Gastroenterol."},{"key":"1457_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamasurg.2021.0546","volume":"156","author":"S Arya","year":"2021","unstructured":"Arya S, Kaji AH, Boermeester MA. PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg. 2021;156:789\u201390. https:\/\/doi.org\/10.1001\/jamasurg.2021.0546.","journal-title":"JAMA Surg"},{"key":"1457_CR23","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"1457_CR24","first-page":"301","volume":"92","author":"M Motta","year":"2001","unstructured":"Motta M, Giugno I, Ruello P, Pistone G, Di Fazio I, Malaguarnera M. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. Minerva Med. 2001;92:301\u20135.","journal-title":"Minerva Med"},{"key":"1457_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0149-2918(95)80048-4","volume":"17","author":"M Malaguarnera","year":"1995","unstructured":"Malaguarnera M, Giugno I, Trovato BA, Panebianco MP, Siciliano R, Ruello P. Lipoprotein(a) concentration in patients with chronic active hepatitis C before and after interferon treatment. Clin Ther. 1995;17:721\u20138. https:\/\/doi.org\/10.1016\/0149-2918(95)80048-4.","journal-title":"Clin Ther"},{"key":"1457_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","volume":"80","author":"S Tsimikas","year":"2022","unstructured":"Tsimikas S, Marcovina SM. Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;80:934\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2022.06.019.","journal-title":"J Am Coll Cardiol"},{"key":"1457_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","volume":"119","author":"S Tsimikas","year":"2009","unstructured":"Tsimikas S, Clopton P, Brilakis ES, et al. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation. 2009;119:1711\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.836940.","journal-title":"Circulation"},{"key":"1457_CR28","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11325-021-02290-7","volume":"25","author":"WA Silva","year":"2021","unstructured":"Silva WA, Almeida-Pititto B, Santos RB, et al. Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort. Sleep Breath. 2021;25:1935\u201344. https:\/\/doi.org\/10.1007\/s11325-021-02290-7.","journal-title":"Sleep Breath"},{"key":"1457_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5664\/jcsm.8242","volume":"16","author":"H Xu","year":"2020","unstructured":"Xu H, Xia Y, Li X, et al. Association between obstructive sleep apnea and lipid metabolism during REM and NREM sleep. J Clin Sleep Med. 2020;16:475\u201382. https:\/\/doi.org\/10.5664\/jcsm.8242.","journal-title":"J Clin Sleep Med"},{"key":"1457_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","volume":"299","author":"K Konishi","year":"2020","unstructured":"Konishi K, Miyake T, Furukawa S, et al. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis. 2020;299:32\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.02.026.","journal-title":"Atherosclerosis."},{"key":"1457_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/hep4.1830","volume":"6","author":"M Meroni","year":"2022","unstructured":"Meroni M, Longo M, Lombardi R, et al. Low lipoprotein(a) levels predict hepatic fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Commun. 2022;6:535\u201349. https:\/\/doi.org\/10.1002\/hep4.1830.","journal-title":"Hepatol Commun"},{"key":"1457_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","volume":"349","author":"B Enkhmaa","year":"2022","unstructured":"Enkhmaa B, Berglund L. Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis. 2022;349:53\u201362. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.04.006.","journal-title":"Atherosclerosis"},{"key":"1457_CR33","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","volume":"74","author":"DF Gudbjartsson","year":"2019","unstructured":"Gudbjartsson DF, Thorgeirsson G, Sulem P, et al. Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes. J Am Coll Cardiol. 2019;74:2982\u201394. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.019.","journal-title":"J Am Coll Cardiol"},{"key":"1457_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S2213-8587(13)70064-0","volume":"1","author":"PR Kamstrup","year":"2013","unstructured":"Kamstrup PR, Nordestgaard BG. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study. Lancet Diabetes Endocrinol. 2013;1:220\u20137. https:\/\/doi.org\/10.1016\/S2213-8587(13)70064-0.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1457_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/db13-1144","volume":"63","author":"Z Ye","year":"2014","unstructured":"Ye Z, Haycock PC, Gurdasani D, et al. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Diabetes. 2014;63:332\u201342. https:\/\/doi.org\/10.2337\/db13-1144.","journal-title":"Diabetes"},{"key":"1457_CR36","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/ijms22084156","volume":"22","author":"Y Sakurai","year":"2021","unstructured":"Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci. 2021;22:4156. https:\/\/doi.org\/10.3390\/ijms22084156.","journal-title":"Int J Mol Sci"},{"key":"1457_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-d","volume":"101","author":"JP Werba","year":"1993","unstructured":"Werba JP, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori CR, Franceschini G. Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population. Atherosclerosis. 1993;101:203\u201311. https:\/\/doi.org\/10.1016\/0021-9150(93)90117-d.","journal-title":"Atherosclerosis"},{"key":"1457_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0021-9150(94)90109-0","volume":"108","author":"W Bartens","year":"1994","unstructured":"Bartens W, Rader DJ, Talley G, Brewer HB Jr. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Atherosclerosis. 1994;108:149\u20137.","journal-title":"Atherosclerosis"},{"key":"1457_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0021-9150(94)90109-0","volume":"145","author":"T Reblin","year":"1999","unstructured":"Reblin T, Hahn KR, Bethge F, Greten H. Quantification of lipoprotein(a) and apolipoprotein(a) in plasma and lipoprotein fractions in the hypertriglyceridemic state. Atherosclerosis. 1999;145:71\u20139. https:\/\/doi.org\/10.1016\/0021-9150(94)90109-0.","journal-title":"Atherosclerosis"},{"key":"1457_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0005-2760(97)00049-0","volume":"1346","author":"C Marcoux","year":"1997","unstructured":"Marcoux C, Lussier-Cacan S, Davignon J, Cohn JS. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects. Biochim Biophys Acta. 1997;1346:261\u201374. https:\/\/doi.org\/10.1016\/s0005-2760(97)00049-0.","journal-title":"Biochim Biophys Acta"},{"key":"1457_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2019.08.015","volume":"289","author":"H Scharnagl","year":"2019","unstructured":"Scharnagl H, Stojakovic T, Dieplinger B, et al. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays. Atherosclerosis. 2019;289:206\u201313. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.015.","journal-title":"Atherosclerosis"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-023-01457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-023-01457-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-023-01457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T09:30:03Z","timestamp":1719999003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-023-01457-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1007\/s12664-023-01457-2","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WM, LB, EG-L, IG and JPN\u00a0declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/ findings and content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}